Hematology Toronto Complement Conference (TCC) 2024: Expert Interview Dr. Christopher Patriquin — Length: 07:49 Proximal Inhibitors in PNH: Addressing Residual Anemia and Improving Quality of Life Watch Presentation
Hematology Toronto Complement Conference (TCC) 2024 November 29-30, 2024 — Toronto, Ontario Paroxysmal Nocturnal Hemoglobinuria: Targeting Unmet Needs with Newest Proximal Complement Inhibitors Download 3 PowerPoint slides
nephrology Toronto Complement Conference (TCC) 2024: Expert Interview Dr. Christoph Licht — Length: 05:40 Phase 3 Trials Highlight Promising Results for Proximal Inhibitors in C3G Watch Presentation
nephrology Toronto Complement Conference (TCC) 2024 November 29-30, 2024 — Toronto, Ontario Emerging Treatment Options for Unmet Need in Complement 3 Glomerulopathy Download 4 PowerPoint slides
nephrology Toronto Complement Conference (TCC) 2024: Expert Interview Dr. Christoph Licht — Length: 03:48 Dysregulation of the Alternative Pathway in Complement 3 Glomerulopathy Watch Presentation
Dermatology European Academy of Dermatology and Venereology (EADV) 2024: Expert Interview Dr. Natalie Cunningham — Length: 04:37 Sustained Control of Pediatric Atopic Dermatitis with As-needed Topical JAK Inhibitor: Evidence from TRuE-AD3 Watch Presentation
Dermatology European Academy of Dermatology and Venereology (EADV) 2024: Expert Interview Dr. Geeta Yadav — Length: 04:04 Insights from the TRuE-V Pivotal Trials: Durable Repigmentation in Vitiligo Following Topical JAK Inhibitor Use Watch Presentation
Infectious Disease HABP and VABP: Expert Discussion Dr. Zhanel & Dr. Rotstein — Length: 14:19 HABP and VABP Treatment: Update and Role of New IV Antimicrobials Watch Presentation
Dermatology European Academy of Dermatology and Venereology (EADV) 2024: Expert Interview Dr. Fiona Lovegrove — Length: 06:27 Exploring Treatment Options for Hidradenitis Suppurativa and Prurigo Nodularis: A Focus on JAK Inhibitors Watch Presentation
ophthalmology Anti-VEGF: eLearning Program Dr. Michael W. Stewart — Length: 20:02 Evolving Strategy for Extending Dosing Intervals: Lessons Learned from PULSAR and PHOTON Watch Presentation
Hematology European Hematology Association (EHA) 2024 Hybrid Congress: Expert Interview Dr. Christopher J. Patriquin — Length: 07:15 Broadening the PNH Treatment Landscape: Updates from APPOINT-PNH & APPLY-PNH Watch Presentation
Cardiology 10th European Stroke Organization Conference (ESOC) 2024 May 15-17, 2024 — Basel, Switzerland Stroke Therapy Targeted at Platelet Glycoprotein Still Considered Promising Despite Negative Trial Download 2 PowerPoint slides
